X

Stay Connected

Sign Up for Updates

We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.

R&D Focus: New report shows nearly 600 medicines in development for pediatric patients

By Andrew Powaleny  |    February 13, 2020
America’s biopharmaceutical researchers are committed to studying, developing and testing medicines to meet the unique needs of pediatric patients. New treatment options for infants, children and...   Read More

Search the Catalyst

View Posts by Topic

see all

Subscribe to Email Updates